User profiles for Irene A. Abela

Irene Alma Abela

University of Zurich
Verified email at virology.uzh.ch
Cited by 1168

[HTML][HTML] Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies

IA Abela, L Berlinger, M Schanz, L Reynell… - PLoS …, 2012 - journals.plos.org
HIV is known to spread efficiently both in a cell-free state and from cell to cell, however the
relative importance of the cell-cell transmission mode in natural infection has not yet been …

Large and small cerebral vessel involvement in severe COVID-19: detailed clinical workup of a case series

…, J Willms, F Porta, A Waeckerlin, M Huber, IA Abela… - Stroke, 2020 - Am Heart Assoc
Background and Purpose: Case series indicating cerebrovascular disorders in coronavirus
disease 2019 (COVID-19) have been published. Comprehensive workups, including clinical …

Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools

A Ulyte, T Radtke, IA Abela, SR Haile, C Berger… - bmj, 2021 - bmj.com
Objectives To examine longitudinal changes in severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) seroprevalence and to determine the clustering of children who were …

[HTML][HTML] Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease

I Busnadiego, IA Abela, PM Frey, DA Hofmaenner… - PLoS …, 2022 - journals.plos.org
Autoantibodies neutralizing the antiviral action of type I interferons (IFNs) have been
associated with predisposition to severe Coronavirus Disease 2019 (COVID-19). Here, we …

[HTML][HTML] Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response

M Marconato, IA Abela, A Hauser… - The Journal of …, 2022 - Am Soc Clin Investig
BACKGROUND Neutralizing antibodies are considered a key correlate of protection by
current SARS-CoV-2 vaccines. The manner in which human infections respond to therapeutic …

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1

…, OF Brandenberg, L Berlinger, IA Abela… - Journal of Experimental …, 2011 - rupress.org
Interference with virus entry is known to be the principle mechanism of HIV neutralization by
antibodies, including 2F5 and 4E10, which bind to the membrane-proximal external region (…

[HTML][HTML] Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity

IA Abela, C Pasin, M Schwarzmüller, S Epp… - Nature …, 2021 - nature.com
Determination of SARS-CoV-2 antibody responses in the context of pre-existing immunity to
circulating human coronavirus (HCoV) is critical for understanding protective immunity. Here …

Antibody response in immunocompromised patients after the administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine BNT162b2 or …

B Speich, F Chammartin, IA Abela… - Clinical infectious …, 2022 - academic.oup.com
Background BNT162b2 by Pfizer-BioNTech and mRNA-1273 by Moderna are the most
commonly used vaccines to prevent severe acute respiratory syndrome coronavirus 2 (SARS-…

[HTML][HTML] Antibody response to SARS-CoV-2 vaccination in patients following allogeneic hematopoietic cell transplantation

…, AS Zinkernagel, A Trkola, MG Manz, IA Abela… - … and cellular therapy, 2022 - Elsevier
Vaccines against SARS-CoV-2 have been rapidly approved. Although pivotal studies were
conducted in healthy volunteers, little information is available on the safety and efficacy of …

[HTML][HTML] Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based …

A Ulyte, T Radtke, IA Abela, SR Haile, J Braun… - International journal of …, 2020 - Springer
Objectives This longitudinal cohort study aims to assess the extent and patterns of
seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in …